BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23788637)

  • 1. Peroxisome proliferator-activated receptor γ (PPARγ) and its target genes are downstream effectors of FoxO1 protein in islet β-cells: mechanism of β-cell compensation and failure.
    Gupta D; Leahy AA; Monga N; Peshavaria M; Jetton TL; Leahy JL
    J Biol Chem; 2013 Aug; 288(35):25440-25449. PubMed ID: 23788637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXO1 transrepresses peroxisome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes.
    Fan W; Imamura T; Sonoda N; Sears DD; Patsouris D; Kim JJ; Olefsky JM
    J Biol Chem; 2009 May; 284(18):12188-97. PubMed ID: 19246449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleo-cytosolic shuttling of FoxO1 directly regulates mouse Ins2 but not Ins1 gene expression in pancreatic beta cells (MIN6).
    Meur G; Qian Q; da Silva Xavier G; Pullen TJ; Tsuboi T; McKinnon C; Fletcher L; Tavaré JM; Hughes S; Johnson P; Rutter GA
    J Biol Chem; 2011 Apr; 286(15):13647-56. PubMed ID: 21335550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression.
    Kim SJ; Winter K; Nian C; Tsuneoka M; Koda Y; McIntosh CH
    J Biol Chem; 2005 Jun; 280(23):22297-307. PubMed ID: 15817464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologic and pharmacologic modulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta-cells by peroxisome proliferator-activated receptor (PPAR)-gamma signaling: possible mechanism for the GIP resistance in type 2 diabetes.
    Gupta D; Peshavaria M; Monga N; Jetton TL; Leahy JL
    Diabetes; 2010 Jun; 59(6):1445-50. PubMed ID: 20332343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells.
    Kibbe C; Chen J; Xu G; Jing G; Shalev A
    J Biol Chem; 2013 Aug; 288(32):23194-202. PubMed ID: 23803610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of FoxO1/ PGC-1α prevents mitochondrial dysfunction and ameliorates mesangial cell injury in diabetic rats.
    Wu L; Wang Q; Guo F; Zhou Y; Ji H; Liu F; Ma X; Zhao Y; Qin G
    Mol Cell Endocrinol; 2015 Sep; 413():1-12. PubMed ID: 26123583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet beta-cell.
    Martinez SC; Cras-Méneur C; Bernal-Mizrachi E; Permutt MA
    Diabetes; 2006 Jun; 55(6):1581-91. PubMed ID: 16731820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FoxO1 Deacetylation Decreases Fatty Acid Oxidation in β-Cells and Sustains Insulin Secretion in Diabetes.
    Kim-Muller JY; Kim YJ; Fan J; Zhao S; Banks AS; Prentki M; Accili D
    J Biol Chem; 2016 May; 291(19):10162-72. PubMed ID: 26984405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice.
    Zhang T; Kim DH; Xiao X; Lee S; Gong Z; Muzumdar R; Calabuig-Navarro V; Yamauchi J; Harashima H; Wang R; Bottino R; Alvarez-Perez JC; Garcia-Ocaña A; Gittes G; Dong HH
    Endocrinology; 2016 Mar; 157(3):1055-70. PubMed ID: 26727107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulinotropic effects of GPR120 agonists are altered in obese diabetic and obese non-diabetic states.
    Zhang D; So WY; Wang Y; Wu SY; Cheng Q; Leung PS
    Clin Sci (Lond); 2017 Feb; 131(3):247-260. PubMed ID: 27980130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FoxO1 as a double-edged sword in the pancreas: analysis of pancreas- and β-cell-specific FoxO1 knockout mice.
    Kobayashi M; Kikuchi O; Sasaki T; Kim HJ; Yokota-Hashimoto H; Lee YS; Amano K; Kitazumi T; Susanti VY; Kitamura YI; Kitamura T
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E603-13. PubMed ID: 22215655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SetD7 (Set7/9) is a novel target of PPARγ that promotes the adaptive pancreatic β-cell glycemic response.
    Jetton TL; Flores-Bringas P; Leahy JL; Gupta D
    J Biol Chem; 2021 Nov; 297(5):101250. PubMed ID: 34592314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A-I increases insulin secretion and production from pancreatic β-cells via a G-protein-cAMP-PKA-FoxO1-dependent mechanism.
    Cochran BJ; Bisoendial RJ; Hou L; Glaros EN; Rossy J; Thomas SR; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2261-7. PubMed ID: 25147338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FoxO feedback control of basal IRS-2 expression in pancreatic β-cells is distinct from that in hepatocytes.
    Tsunekawa S; Demozay D; Briaud I; McCuaig J; Accili D; Stein R; Rhodes CJ
    Diabetes; 2011 Nov; 60(11):2883-91. PubMed ID: 21933986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase Cδ regulates nuclear export of FOXO1 through phosphorylation of the chaperone 14-3-3ζ.
    Gerst F; Kaiser G; Panse M; Sartorius T; Pujol A; Hennige AM; Machicao F; Lammers R; Bosch F; Häring HU; Ullrich S
    Diabetologia; 2015 Dec; 58(12):2819-31. PubMed ID: 26363783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity.
    Armoni M; Harel C; Karni S; Chen H; Bar-Yoseph F; Ver MR; Quon MJ; Karnieli E
    J Biol Chem; 2006 Jul; 281(29):19881-91. PubMed ID: 16670091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of forkhead box O1 (FOXO1) by protein kinase B and glucocorticoids: different mechanisms of induction of beta cell death in vitro.
    Kaiser G; Gerst F; Michael D; Berchtold S; Friedrich B; Strutz-Seebohm N; Lang F; Häring HU; Ullrich S
    Diabetologia; 2013 Jul; 56(7):1587-95. PubMed ID: 23435785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forkhead box O1/pancreatic and duodenal homeobox 1 intracellular translocation is regulated by c-Jun N-terminal kinase and involved in prostaglandin E2-induced pancreatic beta-cell dysfunction.
    Meng Z; Lv J; Luo Y; Lin Y; Zhu Y; Nie J; Yang T; Sun Y; Han X
    Endocrinology; 2009 Dec; 150(12):5284-93. PubMed ID: 19837872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forkhead box O1 mediates defects in palmitate-induced insulin granule exocytosis by downregulation of calcium/calmodulin-dependent serine protein kinase expression in INS-1 cells.
    Wang Y; Lin H; Hao N; Zhu Z; Wang D; Li Y; Chen H; Zhu Y; Han X
    Diabetologia; 2015 Jun; 58(6):1272-81. PubMed ID: 25796372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.